Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Litton

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
The Oncologist|April 12, 2013
Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancerJennifer K Litton, Carla L Warneke, Karin M Hahn, et al.
European Journal of Breast Health|October 5, 2023
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer ChemopreventionFatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, et al.
Breast Cancer Research and Treatment|August 11, 2011
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsSoley Bayraktar, Angelica M Gutierrez-Barrera, Diane Liu, et al.
Clinical & Experimental Metastasis|February 2, 2013
Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutationsS Bayraktar, A M Gutierrez-Barrera, H Lin, et al.
Journal of Cancer|August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor DiscontinuationSami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.
Scientific Reports|November 16, 2021
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancerMegumi Kai, Angela N Marx, Diane D Liu, et al.
NPJ Breast Cancer|May 10, 2022
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancersXuan Liu, Zhongqi Ge, Fei Yang, et al.
The Oncologist|June 22, 2014
Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosisAshley H Woodson, Kimberly I Muse, Heather Lin, et al.
Clinical Immunology (Orlando, Fla.)|July 21, 2018
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial designDoreen O Jackson, Francois A Trappey, G Travis Clifton, et al.
JCO Precision Oncology|September 26, 2019
Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and OutcomesMolly Daniels, Chetna Wathoo, Lauren Brusco, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
The Oncologist|April 12, 2013
Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancerJennifer K Litton, Carla L Warneke, Karin M Hahn, et al.
European Journal of Breast Health|October 5, 2023
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer ChemopreventionFatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, et al.
Breast Cancer Research and Treatment|August 11, 2011
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsSoley Bayraktar, Angelica M Gutierrez-Barrera, Diane Liu, et al.
Clinical & Experimental Metastasis|February 2, 2013
Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutationsS Bayraktar, A M Gutierrez-Barrera, H Lin, et al.
Journal of Cancer|August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor DiscontinuationSami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.
Scientific Reports|November 16, 2021
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancerMegumi Kai, Angela N Marx, Diane D Liu, et al.
NPJ Breast Cancer|May 10, 2022
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancersXuan Liu, Zhongqi Ge, Fei Yang, et al.
The Oncologist|June 22, 2014
Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosisAshley H Woodson, Kimberly I Muse, Heather Lin, et al.
Clinical Immunology (Orlando, Fla.)|July 21, 2018
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial designDoreen O Jackson, Francois A Trappey, G Travis Clifton, et al.
JCO Precision Oncology|September 26, 2019
Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and OutcomesMolly Daniels, Chetna Wathoo, Lauren Brusco, et al.
Pageof 17